Cargando…

A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities

PURPOSE: Recent randomized controlled trials evaluating stereotactic surgery (SRS) for resected brain metastases question the high rates of local control previously reported in retrospective studies. Tumor control probability (TCP) models were developed to quantify the relationship between radiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Gui, Chengcheng, Grimm, Jimm, Kleinberg, Lawrence Richard, Zaki, Peter, Spoleti, Nicholas, Mukherjee, Debraj, Bettegowda, Chetan, Lim, Michael, Redmond, Kristin Janson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557194/
https://www.ncbi.nlm.nih.gov/pubmed/33083646
http://dx.doi.org/10.1016/j.adro.2020.06.007
_version_ 1783594366780047360
author Gui, Chengcheng
Grimm, Jimm
Kleinberg, Lawrence Richard
Zaki, Peter
Spoleti, Nicholas
Mukherjee, Debraj
Bettegowda, Chetan
Lim, Michael
Redmond, Kristin Janson
author_facet Gui, Chengcheng
Grimm, Jimm
Kleinberg, Lawrence Richard
Zaki, Peter
Spoleti, Nicholas
Mukherjee, Debraj
Bettegowda, Chetan
Lim, Michael
Redmond, Kristin Janson
author_sort Gui, Chengcheng
collection PubMed
description PURPOSE: Recent randomized controlled trials evaluating stereotactic surgery (SRS) for resected brain metastases question the high rates of local control previously reported in retrospective studies. Tumor control probability (TCP) models were developed to quantify the relationship between radiation dose and local control after SRS for resected brain metastases. METHODS AND MATERIALS: Patients with resected brain metastases treated with SRS were evaluated retrospectively. Melanoma, sarcoma, and renal cell carcinoma were considered radio-resistant histologies. The planning target volume (PTV) was the region of enhancement on T1 post-gadolinium magnetic resonance imaging plus a 2-mm uniform margin. The primary outcome was local recurrence, defined as tumor progression within the resection cavity. Cox regression evaluated predictors of local recurrence. Dose-volume histograms for the PTV were obtained from treatment plans and converted to 3-fraction equivalent doses (α/β = 12 Gy). TCP models evaluated local control at 1-year follow-up as a logistic function of dose-volume histogram data. RESULTS: Among 150 cavities, 41 (27.3%) were radio-resistant. The median PTV volume was 14.6 mL (range, 1.3-65.3). The median prescription was 21 Gy (range, 15-25) in 3 fractions (range, 1-5). Local control rates at 12 and 24 months were 86% and 82%. On Cox regression, larger cavities (PTV > 12 cm(3)) predicted increased risk of local recurrence (P = .03). TCP modeling demonstrated relationships between improved 1-year local control and higher radiation doses delivered to radio-resistant cavities. Maximum PTV doses of 30, 35, and 40 Gy predicted 78%, 89%, and 94% local control among all radio-resistant cavities, versus 69%, 79%, and 86% among larger radio-resistant cavities. CONCLUSIONS: After SRS for resected brain metastases, larger cavities are at greater risk of local recurrence. TCP models suggests that higher radiation doses may improve local control among cavities of radio-resistant histology. Given maximum tolerated doses established for single-fraction SRS, fractionated regimens may be required to optimize local control in large radio-resistant cavities.
format Online
Article
Text
id pubmed-7557194
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75571942020-10-19 A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities Gui, Chengcheng Grimm, Jimm Kleinberg, Lawrence Richard Zaki, Peter Spoleti, Nicholas Mukherjee, Debraj Bettegowda, Chetan Lim, Michael Redmond, Kristin Janson Adv Radiat Oncol Scientific Article PURPOSE: Recent randomized controlled trials evaluating stereotactic surgery (SRS) for resected brain metastases question the high rates of local control previously reported in retrospective studies. Tumor control probability (TCP) models were developed to quantify the relationship between radiation dose and local control after SRS for resected brain metastases. METHODS AND MATERIALS: Patients with resected brain metastases treated with SRS were evaluated retrospectively. Melanoma, sarcoma, and renal cell carcinoma were considered radio-resistant histologies. The planning target volume (PTV) was the region of enhancement on T1 post-gadolinium magnetic resonance imaging plus a 2-mm uniform margin. The primary outcome was local recurrence, defined as tumor progression within the resection cavity. Cox regression evaluated predictors of local recurrence. Dose-volume histograms for the PTV were obtained from treatment plans and converted to 3-fraction equivalent doses (α/β = 12 Gy). TCP models evaluated local control at 1-year follow-up as a logistic function of dose-volume histogram data. RESULTS: Among 150 cavities, 41 (27.3%) were radio-resistant. The median PTV volume was 14.6 mL (range, 1.3-65.3). The median prescription was 21 Gy (range, 15-25) in 3 fractions (range, 1-5). Local control rates at 12 and 24 months were 86% and 82%. On Cox regression, larger cavities (PTV > 12 cm(3)) predicted increased risk of local recurrence (P = .03). TCP modeling demonstrated relationships between improved 1-year local control and higher radiation doses delivered to radio-resistant cavities. Maximum PTV doses of 30, 35, and 40 Gy predicted 78%, 89%, and 94% local control among all radio-resistant cavities, versus 69%, 79%, and 86% among larger radio-resistant cavities. CONCLUSIONS: After SRS for resected brain metastases, larger cavities are at greater risk of local recurrence. TCP models suggests that higher radiation doses may improve local control among cavities of radio-resistant histology. Given maximum tolerated doses established for single-fraction SRS, fractionated regimens may be required to optimize local control in large radio-resistant cavities. Elsevier 2020-06-24 /pmc/articles/PMC7557194/ /pubmed/33083646 http://dx.doi.org/10.1016/j.adro.2020.06.007 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Scientific Article
Gui, Chengcheng
Grimm, Jimm
Kleinberg, Lawrence Richard
Zaki, Peter
Spoleti, Nicholas
Mukherjee, Debraj
Bettegowda, Chetan
Lim, Michael
Redmond, Kristin Janson
A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities
title A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities
title_full A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities
title_fullStr A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities
title_full_unstemmed A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities
title_short A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities
title_sort dose-response model of local tumor control probability after stereotactic radiosurgery for brain metastases resection cavities
topic Scientific Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557194/
https://www.ncbi.nlm.nih.gov/pubmed/33083646
http://dx.doi.org/10.1016/j.adro.2020.06.007
work_keys_str_mv AT guichengcheng adoseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT grimmjimm adoseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT kleinberglawrencerichard adoseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT zakipeter adoseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT spoletinicholas adoseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT mukherjeedebraj adoseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT bettegowdachetan adoseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT limmichael adoseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT redmondkristinjanson adoseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT guichengcheng doseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT grimmjimm doseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT kleinberglawrencerichard doseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT zakipeter doseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT spoletinicholas doseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT mukherjeedebraj doseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT bettegowdachetan doseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT limmichael doseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities
AT redmondkristinjanson doseresponsemodeloflocaltumorcontrolprobabilityafterstereotacticradiosurgeryforbrainmetastasesresectioncavities